Cumberland Pharmaceuticals Inc CPIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
CPIX Investors Have Opportunity to Join Cumberland Pharmaceuticals Inc. Fraud Investigation with SBS Law
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS
CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAM
Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
Trading Information
- Previous Close Price
- $5.01
- Day Range
- $4.44–5.32
- 52-Week Range
- $1.88–9.28
- Bid/Ask
- $5.14 / $5.50
- Shares Outstanding
- 14.98M
- Market Cap
- $78.21M
- Volume/Avg
- 84,379 / 89,419
Key Statistics
- Price/Earnings (Normalized)
- 40.28
- Price/Sales
- 3.48
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.09%
Company Profile
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 93
Valuation
Metric | CPIX |
|---|---|
Price/Earnings (Normalized) | 40.28 |
Price/Book Value | 4.49 |
Price/Sales | 3.48 |
Price/Cash Flow | — |
Price/Earnings
CPIX
Financial Strength
Metric | CPIX |
|---|---|
Quick Ratio | 0.49 |
Current Ratio | 0.96 |
Interest Coverage | −42.20 |
Quick Ratio
CPIX
Profitability
Metric | CPIX |
|---|---|
Return on Assets (Normalized) | −9.95% |
Return on Equity (Normalized) | −29.02% |
Return on Invested Capital (Normalized) | −21.49% |
Return on Assets
CPIX
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|??T!QV? | LOCK|XfBnx | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|Fd%!CQ% | LOCK|@V@S# | $48B | |||
| Haleon PLC ADR HLN | LOCK|#xl%<f@ | LOCK|#mj | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|t$fWN?$% | LOCK|<S | $32B | |||
| Viatris Inc VTRS | LOCK|C@JC$@ | LOCK|&lC | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|Qr | LOCK|m# | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|?S?mm$ | LOCK|Nk | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|Ph&&%!% | LOCK|Hkd | $6B | |||
| Perrigo Co PLC PRGO | LOCK|rX&LdP% | LOCK|vBb | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|<!^&!b | LOCK|^&$^ | $2B |
United States